Navigation Links
Surprise discovery made in cancer research

This release is available in German.

One of the defining characteristics of cancer cells is that they systematically prevent programmed cell death (apoptosis), with which the body guards itself against the proliferation of defective cells. In order to do this, they express so-called apoptosis inhibitors (IAPs) among other proteins.

Many of the cancer drugs currently undergoing clinical trials target IAPs, since if the levels of IAPs are reduced, tumour cells will be destroyed by the body's own self-protecting mechanism or by the chemotherapeutic drugs. However, as a research group from the Goethe University in Frankfurt, working with scientists at the Universities of Wrzburg and Philadelphia have recently discovered, IAPs also have another life: they control cell migration. Where IAP production is suppressed, there is a significant increase in C-RAF kinase, a crucial member of a signal cascade, which, among other functions, controls cell migration. This also means that when IAP levels are reduced, metastasis may be promoted unexpectedly in the absence of cell death. According to the researchers, drugs to target IAPs should therefore only be used with caution in future.

Dr. Krishnaraj Rajalingam, leader of the Emmy-Noether Group at the Institute for Biochemistry at Frankfurt's Goethe University, claims that these findings have been a great surprise. As he puts it: "Up until now, IAPs were well known for their role in apoptosis suppression, but we now realise that they can also influence other processes like cell migration". The classical mitogenic cascade (MAPK) is triggered by RAS proteins, which are activated by mutations in nearly 20 % of all human tumours. In this signalling cascade, the RAS-protein is immediately followed by the C-RAF kinase, which as the researchers report in the current issue of 'Nature Cell Biology' binds strongly to an apoptosis inhibitor (XIAP). "If we reduce the expression of some IAPs by RNA interference technique, C-RAF kinase increases in both the healthy and the cancerous human cells. As a consequence, the cells alter their form and start to move faster." Co-author Prof. Ulf R. Rapp from the University of Wrzburg, who discovered C-RAF kinase 25 years ago, claims that these findings will have a significant influence on cancer therapy.

Prof. Werner-Mller Esterl, Director of Frankfurt's Institute for Biochemistry II and the President-elect of the Goethe University, is delighted by the success of his young colleague, who took up his post at the university only a few months ago. "These are very exciting results and with such an early success, our new Emmy Noether Group has proved that the University's programme of supporting young independent scientific investigators has once again paid off."


Contact: Krishnaraj Rajalingam
Goethe University Frankfurt

Related medicine news :

1. Blue Cross/Blue Shield Christmas Gift to Federal Employees: Surprise, Were Cutting Your Benefits!; Patients, Doctors and Health Care Providers Outraged
2. Hey fever! The surprise benefit of allergies
3. NARALS CHOICE: Is Anyone Surprised About Out-of-the-Mainstream NARALs Choice of Barack Obama for President?
4. This Mothers Day, Surprise Mom With a New Way to Give
5. Easter Eggs May Hold Some Unwanted Surprises
6. Surprise Orgasms Baffle Women Undergoing New Infertility Treatment
7. Surprise U.S. Supreme Court Decision Helps Michigan Citizens
8. Surprise in Lab Helps ID Drug to Fight ALS
9. Med school discovery could lead to better cancer diagnosis, drugs
10. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
11. Leeds researchers reshape the future of drug discovery
Post Your Comments:
Related Image:
Surprise discovery made in cancer research
(Date:10/13/2015)... ... October 13, 2015 , ... ... IBM software products, introduced a new company, RightSensor™ LLC, an Internet of Things ... capability. RightSensor™ provides a fully-managed approach for customers requiring sensor hardware for ...
(Date:10/13/2015)... ... October 13, 2015 , ... e-con Systems Inc., a leading embedded ... See3CAM_CU40, the industry’s first RGB-IR pixel format camera with a USB 3.0 interface ... e-con’s See3CAM family of UVC USB 3.0 cameras, is based on the 1/3-inch OV4682 ...
(Date:10/13/2015)... ... ... Protein is essential to good health. You need it to make the bricks ... does the average man need in order to stay healthy? , The answer ... Harvard Men's Health Watch . Most Americans get about 15% of their calories ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... in McHenry County, Illinois with more than 59,000 emergency department visits per year, ... system (EDIS) from T-System, to help improve clinical, operational and financial outcomes. ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... World ... Driveway Snow Blanket, a snow melting invention that helps people in clearing snow away ... and will continue to grow at 3.8% per year," says Scott Cooper, CEO and ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... N.C. , Oct. 13, 2015  Yesterday Congresswoman ... Influenza Vaccines Holly Springs manufacturing site located in ... 2014, the facility has produced Flucelvax ® (Influenza ... the potential for faster start-up and is not reliant ... CSL Limited acquired the influenza vaccines business of Novartis ...
(Date:10/12/2015)... 12, 2015 Given the intricacy of ... challenging to deliver an ophthalmic drug effectively to a specific ... successful ocular drug delivery. These include dilution of a drug ... of conjunctiva and drug permeation issues with respect to the ... topical eye drops, is lost due to the aforementioned barriers. ...
(Date:10/12/2015)... CRANBURY, N.J. , Oct. 12, 2015 /PRNewswire/ ... that a securities fraud class action complaint was ... of New Jersey.  The complaint alleges that officers and ... Securities Exchange Act of 1934 between September 15, 2015 ... misleading statements about Amicus Therapeutics, business prospects.  Amicus is ...
Breaking Medicine Technology: